Coherus BioSciences Inc. News
FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.
Coherus was cleared by the FDA for a drug that's similar to AbbVie's Humira. Coherus plans to launch the psoriasis treatment in July 2023.
Five Below, Splunk, Snap: 'Mad Money' Lightning Round
Jim Cramer weighs in on Five Below, Splunk, Snap, Crown Castle, Square, 3D Systems, Dana, Alibaba, Coherus Biosciences.
Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
Even with Monday's sharp reversal, Jim Cramer says he still likes this market.
Here's what blackstone bought and sold in the fourth quarter
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
Bed, Bath & Beyond Stock Plummets As Ryan Cohen Nets $60 Million From Activist Exit
GameStop chairman Ryan Cohen completed his exit from an activist stake in Bed, Bath & Beyond Thursday after riding a meme-lead rally to a near $60 million in profits.
Home Depot Stock Gains On $15 Billion Buyback, $1.90 Dividend; Ted Decker Named Chairman
Home Depot closed out a busy week by naming CEO Ted Decker as chairman, unveiling a new $15 billion buyback and declaring a $1.90 per share dividend.
Applied Materials Stock Lower After Q3 Earnings, Chip Market Caution
"Although we're confident in our ability to perform well in a range of market scenarios, we're mindful of the current macroeconomic trends," said CEO Gary Dickerson.
Deere Stock Tumbles As Supply Chain Pressures Bring Q3 Earnings Miss, Profit Forecast Cut
Deere's third quarter profits "reflected higher costs and production inefficiencies driven by the difficult supply-chain situation," said CEO John May.